Asian stocks cling to gains as Fed taper worries ease

3 minute read
Register now for FREE unlimited access to Reuters.com
  • Asian stock markets:
  • Pfizer/BioNTech vaccine gets full approval
  • Oil prices edge up after rallying 5% on Monday
  • Beaten-down China tech stocks advance for second session

SINGAPORE, Aug 24 (Reuters) - A bounce in China's tech sector led Asian stocks higher on Tuesday and markets were also cheered by positive U.S. vaccination news and easing worries about an imminent tapering of stimulus by the Federal Reserve.

Nasdaq and S&P 500 futures both rose 0.15%, while European stocks markets were set for a strong opening, with Euro Stoxx 50 futures up 0.19% and German DAX futures gaining 0.16%.

The dollar was licking its wounds after its sharpest one- day fall since May, which spurred a 5% rally in oil prices on Monday.

Register now for FREE unlimited access to Reuters.com

Spiking COVID-19 infections caused by the highly contagious Delta variant have fuelled concerns about the recovery from the global health crisis.

"The market is hopeful that the Delta variant will prevent the Fed from doing anything too aggressively or too soon," said Vasu Menon, senior investment strategist at OCBC Bank Wealth Management.

MSCI's broadest index of Asia-Pacific shares outside Japan (.MIAPJ0000PUS) rallied 1.3%, with Japan (.N225) and South Korean (.KS11) indexes jumping 1%. Australia shares (.AXJO) were up 0.2% and Taiwan stocks (.TWII) rose 0.6%.

"Clearly, this tug of war will not end anytime soon. But the silver lining is that there is cautious optimism in the market and there's also a lot of liquidity waiting on the sidelines," said Menon.

Data overnight showed strong albeit slowing services and manufacturing activity in Europe while business activity growth in the United States slowed for a third straight month as the spread of the Delta virus variant took a toll. read more

Chinese markets (.CSI300) advanced 1.1%, with technology stocks (.HSTECH) extending their recovery after enduring a pummelling in recent weeks on regulatory worries.

Wall Street's strength underpinned sentiment in Asia. The Nasdaq (.IXIC) closed at a record high on Monday after the U.S. Food and Drug Administration granted full approval to the COVID-19 vaccine developed by Pfizer (PFE.N) and BioNTech, a move that could accelerate inoculations in the United States. read more

Global markets took a beating last week on worries the Fed is edging closer to tapering its stimulus, with Asia's main index tumbling 4.8% to be down 3% for the year.

The improved sentiment overnight drove the dollar down more than 1% against its Australian and Canadian counterparts as well as the Norwegian crown and Swedish crown.

"A positive risk backdrop has pushed flows out of the dollar," said Chris Weston, head of research at brokerage Pepperstone in Melbourne, adding that positive analyst commentary around oil and cyclical stocks had also helped the broad mood.

The dollar rose 0.1% against the yen to 109.79 . The euro was down 0.0% on the day at $1.1741, having lost 1.1% in a month, while the dollar index , which tracks the greenback against a basket of currencies of other major trading partners, was up at 93.005.

Last week, the dollar index hit a nine-month high on bets the Fed would start shifting away from its accommodative monetary policy, but that view began to change on Friday when Dallas Fed President Robert Kaplan said he might reconsider his hawkish stance if the virus harms the economy. read more

Now, investors are less confident Fed Chair Jerome Powell's speech at Jackson Hole this week will indicate a timeline for winding down the Fed's bond-buying program.

The yield on benchmark 10-year Treasury notes rose to 1.2684%.

In commodities markets, Brent crude oil futures added 0.4% to $69 a barrel after rallying more than 5% on Monday, as a weaker dollar and strong global equities markets boosted crude following seven sessions of declines.

Gold prices eased but stayed above the key psychological level of $1,800. [GOL/

Register now for FREE unlimited access to Reuters.com
Reporting by Anshuman Daga in Singapore; Additional reporting by Tom Westbrook; Editing by Shri Navaratnam and Sam Holmes

Our Standards: The Thomson Reuters Trust Principles.